HYPERION DEFI, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
HYPERION DEFI, INC. (HYPD) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $3.84 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-13
- HYPERION DEFI, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $3.84M, a 748.34% increase year-over-year.
- HYPERION DEFI, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $483.65K, a 10.61% decline year-over-year.
- HYPERION DEFI, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-03-31 was $279.63K, a 48.81% decline year-over-year.
- HYPERION DEFI, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2024-09-30 was $453.00K, a 26.10% decline year-over-year.
- HYPERION DEFI, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $1.70M, a 31.77% decline from fiscal 2023.
- HYPERION DEFI, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $2.50M, a 33.66% decline from fiscal 2022.
- HYPERION DEFI, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $3.77M, a 30.47% increase from fiscal 2021.
- HYPERION DEFI, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2021 was $2.89M, a 16.23% increase from fiscal 2020.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2025-09-30 | $3.84M 10-Q · filed 2025-11-14 | $4.33M derived: sum of 2 quarters · filed 2026-08-13 | $4.61M derived: sum of 3 quarters · filed 2026-08-13 | |
| 2025-06-30 | $483.65K 10-Q · filed 2026-08-13 | $763.28K derived: sum of 2 quarters · filed 2026-08-13 | ||
| 2025-03-31 | $279.63K 10-Q · filed 2026-08-13 | |||
| 2024-12-31 | $1.70M 10-K · filed 2025-04-15 | |||
| 2024-09-30 | $453.00K 10-Q · filed 2025-11-14 | $994.05K derived: sum of 2 quarters · filed 2025-11-14 | $1.54M derived: sum of 3 quarters · filed 2025-11-14 | |
| 2024-06-30 | $541.06K 10-Q · filed 2025-11-14 | $1.09M derived: sum of 2 quarters · filed 2025-11-14 | ||
| 2024-03-31 | $546.23K 10-Q · filed 2025-11-14 | |||
| 2023-12-31 | $2.50M 10-K · filed 2025-04-15 | |||
| 2023-09-30 | $612.97K 10-Q · filed 2024-11-12 | $1.11M derived: sum of 2 quarters · filed 2024-11-12 | $1.93M derived: sum of 3 quarters · filed 2024-11-12 | |
| 2023-06-30 | $493.63K 10-Q · filed 2024-11-12 | $1.31M derived: sum of 2 quarters · filed 2024-11-12 | ||
| 2023-03-31 | $819.06K 10-Q · filed 2024-11-12 | |||
| 2022-12-31 | $3.77M 10-K · filed 2024-03-18 | |||
| 2022-09-30 | $928.73K 10-Q · filed 2023-11-13 | $1.97M derived: sum of 2 quarters · filed 2023-11-13 | $2.87M derived: sum of 3 quarters · filed 2023-11-13 | $3.69M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $1.04M 10-Q · filed 2023-11-13 | $1.95M derived: sum of 2 quarters · filed 2023-11-13 | $2.76M derived: sum of 3 quarters · filed 2023-11-13 | $3.54M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-03-31 | $908.99K 10-Q · filed 2023-11-13 | $1.72M derived: sum of 2 quarters · filed 2023-11-13 | $2.50M derived: sum of 3 quarters · filed 2023-11-13 | $3.14M derived: sum of 4 quarters · filed 2023-11-13 |
| 2021-12-31 | $814.37K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.59M derived: sum of 2 quarters · filed 2023-03-31 | $2.23M derived: sum of 3 quarters · filed 2023-03-31 | $2.89M 10-K · filed 2023-03-31 |
| 2021-09-30 | $777.47K 10-Q · filed 2022-11-14 | $1.41M derived: sum of 2 quarters · filed 2022-11-14 | $2.07M 10-Q · filed 2021-11-12 | $2.73M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $637.36K 10-Q · filed 2022-11-14 | $1.29M 10-Q · filed 2021-08-12 | $1.95M derived: sum of 3 quarters · filed 2022-11-14 | $2.56M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-03-31 | $656.91K 10-Q · filed 2022-11-14 | $1.31M derived: sum of 2 quarters · filed 2022-11-14 | $1.92M derived: sum of 3 quarters · filed 2022-11-14 | $2.56M derived: sum of 4 quarters · filed 2022-11-14 |
| 2020-12-31 | $656.23K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $1.27M derived: sum of 2 quarters · filed 2022-03-30 | $1.90M derived: sum of 3 quarters · filed 2022-03-30 | $2.48M 10-K · filed 2022-03-30 |
| 2020-09-30 | $609.93K 10-Q · filed 2021-11-12 | $1.24M derived: sum of 2 quarters · filed 2021-11-12 | $1.83M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $633.15K 10-Q · filed 2021-11-12 | $1.22M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $583.87K 10-Q · filed 2021-11-12 | |||
| 2019-12-31 | $2.51M 10-K · filed 2021-03-30 | |||
| 2019-09-30 | $476.84K 10-Q · filed 2020-11-12 | $900.86K derived: sum of 2 quarters · filed 2020-11-12 | $1.93M derived: sum of 3 quarters · filed 2020-11-12 | |
| 2019-06-30 | $424.02K 10-Q · filed 2020-11-12 | $1.46M derived: sum of 2 quarters · filed 2020-11-12 | ||
| 2019-03-31 | $1.03M 10-Q · filed 2020-11-12 | |||
| 2018-12-31 | $1.62M 10-K · filed 2020-03-30 | |||
| 2018-09-30 | $462.95K 10-Q · filed 2019-11-13 | $464.46K derived: sum of 2 quarters · filed 2019-11-13 | $1.12M derived: sum of 3 quarters · filed 2019-11-13 | |
| 2018-06-30 | $1.51K 10-Q · filed 2019-11-13 | $652.09K derived: sum of 2 quarters · filed 2019-11-13 | ||
| 2018-03-31 | $650.58K 10-Q · filed 2019-11-13 | |||
| 2017-12-31 | $412.31K 10-K · filed 2019-03-27 | |||
| 2016-12-31 | $2.69K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |